|
Post by biotec on Dec 11, 2013 10:29:29 GMT -5
Have any of you looked into Mannkinds other drugs in their pipeline? Theres a couple interesting things Mannkind is working on. I know they gave a company the rights to further pursue one of the drugs in the pipeline this past summer. Does any of this hold wieght as for the value of the company? Not sure how early in the stage those drugs are in.
|
|
|
Post by thsloppy on Dec 11, 2013 11:40:36 GMT -5
It is difficult to assign any value to anything besides Afrezza at this time. Most programs were halted or cut due to cost. Yes I know we see little bits and pieces of curing cancer and using technosphere for pain etc. I'm sure someone may even question or want to research the delivery platform which would be nice but whether Afrezza gets approved and partnered; or not determines the whole future of the company front a current investment thesis
|
|
|
Post by brentie on Dec 11, 2013 11:48:42 GMT -5
|
|
|
Post by goyocafe on Dec 11, 2013 12:52:29 GMT -5
Have any of you looked into Mannkinds other drugs in their pipeline? Theres a couple interesting things Mannkind is working on. I know they gave a company the rights to further pursue one of the drugs in the pipeline this past summer. Does any of this hold wieght as for the value of the company? Not sure how early in the stage those drugs are in. Didn't Al start into some thought about a new partnership at a conference this past Spring/Summer and was quickly hushed by Matt? Haven't heard anything since, but curious what that was all about.
|
|
|
Post by brentie on Dec 11, 2013 15:51:54 GMT -5
Have any of you looked into Mannkinds other drugs in their pipeline? Theres a couple interesting things Mannkind is working on. I know they gave a company the rights to further pursue one of the drugs in the pipeline this past summer. Does any of this hold wieght as for the value of the company? Not sure how early in the stage those drugs are in. Didn't Al start into some thought about a new partnership at a conference this past Spring/Summer and was quickly hushed by Matt? Haven't heard anything since, but curious what that was all about. Yeah, Goyo that was at the Annual Shareholders Meeting. I never heard anymore on the subject after that either. How are you valuing the Technosphere technology beyond Afrezza?We are working with a company now to apply Technosphere to their products. (Al turns to Hakan Edstrom or David Thompson and asks if we are allowed to disclose the company and he is told NO).I’m sorry, but I can’t tell you the company. agoracom.com/ir/Mannkind/forums/discussion/topics/574790-2013-mannkind-annual-stockholders-meeting-notes/?message_id=1804162#message_1804162
|
|